Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?

Ovarian cancer is the most lethal gynecological malignancy. Poor overall survival, particularly for patients with high grade serous (HGS) ovarian cancer, is often attributed to late stage at diagnosis and relapse following chemotherapy. HGS ovarian cancer is a heterogenous disease in that few genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Lynn, Cowden Dahl, Karen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116003/
https://www.ncbi.nlm.nih.gov/pubmed/30042330
http://dx.doi.org/10.3390/cancers10080241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116003/
https://www.ncbi.nlm.nih.gov/pubmed/30042330
http://dx.doi.org/10.3390/cancers10080241

Ejemplares similares